HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Padovani Selected Research

Neurologic Manifestations (Neurological Manifestations)

12/2020Effortful speech with distortion of prosody following SARS-CoV-2 infection.
6/2020Neurological manifestations associated with COVID-19: a review and a call for action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Padovani Research Topics

Disease

78Alzheimer Disease (Alzheimer's Disease)
05/2024 - 01/2002
46Dementia (Dementias)
05/2024 - 01/2002
34Frontotemporal Dementia (Semantic Dementia)
10/2023 - 09/2005
31Cognitive Dysfunction
04/2024 - 01/2002
26Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
05/2024 - 08/2006
25Parkinson Disease (Parkinson's Disease)
12/2024 - 11/2009
25Stroke (Strokes)
06/2023 - 03/2002
20Migraine Disorders (Migraine)
11/2023 - 09/2005
20Ischemic Stroke
01/2022 - 03/2002
17Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 01/2010
14Disease Progression
11/2023 - 06/2003
14COVID-19
10/2023 - 01/2020
14Atrophy
01/2022 - 02/2011
12Headache (Headaches)
01/2024 - 01/2006
12Atrial Fibrillation
06/2023 - 01/2012
9Parkinsonian Disorders (Parkinsonism)
11/2023 - 10/2004
9Pain (Aches)
02/2023 - 12/2007
8Hemorrhage
12/2020 - 08/2010
7Amyloidosis
01/2023 - 12/2016
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2023 - 01/2016
6Primary Progressive Aphasia
01/2023 - 01/2012
5Inflammation (Inflammations)
05/2024 - 07/2013
5Ataxia (Dyssynergia)
06/2023 - 12/2007
5Hematoma
01/2023 - 08/2010
5Blood Vessel Dissection
12/2011 - 01/2002
4Neuroinflammatory Diseases
05/2024 - 10/2020
4Multiple System Atrophy
11/2023 - 08/2007
4Leukocytosis (Pleocytosis)
10/2023 - 01/2020
4Encephalitis (Encephalitis, Rasmussen)
10/2023 - 01/2020
4Neurobehavioral Manifestations
09/2023 - 07/2004
4Cerebral Hemorrhage
01/2023 - 01/2018
4Hypertension (High Blood Pressure)
10/2021 - 02/2004
4Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
09/2019 - 03/2015
4Mitochondrial Diseases (Mitochondrial Disease)
10/2018 - 09/2012
4Epilepsy (Aura)
05/2013 - 07/2009
3Fatigue
01/2024 - 12/2015
3Frailty
01/2024 - 01/2020
3Brain Diseases (Brain Disorder)
10/2023 - 04/2014
3Glycogen Storage Disease Type II (Pompe's Disease)
01/2023 - 10/2013
3Seizures (Absence Seizure)
01/2021 - 07/2009
3Synucleinopathies
12/2020 - 07/2011
3Glycogen Storage Disease (Glycogenosis)
01/2019 - 10/2013
3Lewy Body Disease (Lewy Body Dementia)
01/2019 - 10/2004
3Muscular Diseases (Myopathy)
01/2019 - 12/2012
3Leukoaraiosis
01/2019 - 08/2010
3Brain Ischemia (Cerebral Ischemia)
01/2016 - 01/2007
3Aphasia (Dysphasia)
02/2015 - 10/2011
3Glioma (Gliomas)
06/2014 - 07/2009

Drug/Important Bio-Agent (IBA)

49Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2002
31Amyloid (Amyloid Fibrils)IBA
01/2023 - 01/2002
24Proteins (Proteins, Gene)FDA Link
10/2023 - 01/2002
15Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2018 - 06/2003
14Apolipoproteins E (ApoE)IBA
04/2024 - 06/2002
14GranulinsIBA
01/2017 - 10/2012
11AnticoagulantsIBA
01/2023 - 02/2014
10ProgranulinsIBA
01/2018 - 07/2008
8Cholinergic Agents (Cholinergics)IBA
01/2022 - 01/2012
7Serotonin (5 Hydroxytryptamine)IBA
05/2024 - 09/2005
6ApolipoproteinsIBA
04/2024 - 02/2004
6Analgesics (Analgesic Drugs)IBA
11/2023 - 01/2006
6Glucose (Dextrose)FDA LinkGeneric
11/2023 - 11/2005
6salicylhydroxamic acid (SHAM)IBA
11/2023 - 10/2015
6SynucleinsIBA
01/2023 - 07/2011
6EnzymesIBA
01/2023 - 06/2005
6CholesterolIBA
01/2016 - 06/2003
5CytokinesIBA
05/2024 - 06/2011
5Dopamine (Intropin)FDA LinkGeneric
11/2023 - 03/2010
5Donepezil (Aricept)FDA LinkGeneric
01/2023 - 06/2002
5Neurotransmitter Agents (Neurotransmitter)IBA
01/2023 - 01/2019
5SteroidsIBA
05/2022 - 01/2013
4Levodopa (L Dopa)FDA LinkGeneric
12/2024 - 02/2016
4Antidepressive Agents (Antidepressants)IBA
05/2024 - 01/2022
4Monoclonal AntibodiesIBA
11/2023 - 01/2022
4DNA (Deoxyribonucleic Acid)IBA
01/2023 - 04/2012
42- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
11/2021 - 04/2007
4Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2020 - 04/2007
4AntibodiesIBA
01/2020 - 09/2007
4Mitochondrial DNA (mtDNA)IBA
04/2019 - 06/2007
4HomocysteineIBA
02/2012 - 03/2002
3Type A Botulinum Toxins (Botox)FDA Link
11/2023 - 01/2018
3DNA-Binding Proteins (DNA Binding Protein)IBA
10/2023 - 01/2015
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2023 - 11/2005
3Acetylcholine (Acetylcholine Chloride)FDA Link
01/2023 - 09/2006
3erenumabIBA
01/2023 - 12/2020
3Tryptamines (Triptans)IBA
01/2022 - 03/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 01/2017
3ORALIT (ORS)IBA
10/2021 - 02/2004
3Vitamin KFDA Link
01/2020 - 04/2012
3GlycogenIBA
01/2019 - 10/2013
3Thymidine PhosphorylaseIBA
10/2018 - 12/2011
3Peptides (Polypeptides)IBA
01/2018 - 11/2010
3LipidsIBA
05/2017 - 06/2009
3Prothrombin (Factor II)IBA
03/2015 - 03/2005
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2015 - 01/2010

Therapy/Procedure

42Therapeutics
01/2024 - 06/2003
17Transcranial Direct Current Stimulation
11/2023 - 10/2011
10Transcranial Magnetic Stimulation
01/2022 - 10/2011
6Secondary Prevention
06/2023 - 05/2009
4Thrombectomy
10/2021 - 03/2017
4Activities of Daily Living (ADL)
01/2020 - 11/2007